Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Amigator, yes those are all valid reasons, however,

I would disagree to this extent:  most growth companies are cash-starved, and probably generating negative cash flow, but in actuality we are just about the opposite.  We don't need loans, we already are public, we have already done the creative financing deals.  We would be the envy of any company in the capital markets --- we have essentially free cash flow to fund future endeavors.  You are staring it right in the face, but don't see it.  Just MHO.

Best


Feb 22, 2007 01:31PM

Feb 22, 2007 01:40PM

Feb 22, 2007 01:44PM

Feb 22, 2007 01:59PM

Feb 22, 2007 02:10PM

Feb 22, 2007 02:18PM

Feb 22, 2007 03:06PM

Feb 22, 2007 03:13PM

Feb 22, 2007 03:23PM

Feb 22, 2007 03:31PM

Feb 23, 2007 09:53AM
Share
New Message
Please login to post a reply